U. Sauer

发表

A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors.

S Seeber, C. Unger, D. Strumberg, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.